General Information of the Compound
| Compound ID |
CP0001471
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol
Show/Hide
|
||||||||||||||||||
| Synonyms |
(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol
CHEMBL1173274
NGHJSSNVKXEBAB-GXFFZTMASA-N
SCHEMBL15007461
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H19NO2
|
||||||||||||||||||
| Molecular Weight |
221.3
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H]1NC(C)(C)CO[C@@]1(O)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H19NO2/c1-10-13(15,11-7-5-4-6-8-11)16-9-12(2,3)14-10/h4-8,10,14-15H,9H2,1-3H3/t10-,13+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
NGHJSSNVKXEBAB-GXFFZTMASA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Clinical Information about the Compound
Drug 1 ( (2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol )
| Drug Name | (2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol | ||
|---|---|---|---|
| Target(s) | |||